Clinical Study
Growth Hormone Therapy Benefits Pituitary Stalk Interruption Syndrome Patients with Short Stature: A Retrospective Study of 75 Han Chinese
Table 1
Initial characteristics of the 75 patients.
| | | GH treated cohort () | Untreated cohort () |
| | Sex (male/female) | 45/6 | 21/3 | | Chronological age before treatment (year) | 18.24 ± 5.11 | 18.96 ± 6.58 | | Bone age (year) | 12.1 (5.0~17.0) | 13.0 (9.0~17.0) | | Delayed bone age (year) | −4.0 (−11.0~−1.0) | −4.0 (−6.0~−1.0) | | Height (SDS) | −2.08 (−6.93~−2.80) | −2.25 (−6.18~−50) | | Familial history | 0 | 0 | | Malformations | 4 | 1 | | Breech presentation (%) | 93.3 | 83.0 | | Perinatal events (%) | 51.1 | 53.3 | | GHD (%) | 100 | 100 | | GHD + ACTH deficiency (%) | 62.2 | 56.6 | | GHD + TSH deficiency (%) | 68.9 | 70.0 | | GHD + LH/FSH deficiency (%) | 95.6 | 86.6 |
|
|
, untreated cohort compared to GH treated cohort.
|
